American Home Products has elected Robert Essner as its next chiefexecutive, effective May 1, 2001, replacing John Stafford, who will remain on the firm's board as chairman. Mr Essner is currently president and chief operating officer at AHP, and will retain this position. Mr. Stafford said that the appointment of Mr Essner "provides for continuity of our strategic direction as a first-tier pharmaceutical company."
He added that, for the past 11 years, his successor has been instrumental in leading AHP's Wyeth-Ayerst pharmaceutical business, and "the company and its shareholders can rely on this orderly process and a dynamic transition plan for the future." In return, Mr Essner paid tribute to Mr Stafford, saying he "transformed AHP from the broadly diversified health and consumer products company it was 15 years ago, to the focused and strong pharmaceutical company it is today." However, among the eulogies, there was no mention of three failed merger attempts overseen by both men.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze